falsefalse

Clinical Updates in Treating Advanced Prostate Cancer - Episode 4

Recent Data on ARPI-Based Combination Regimens

,

Panelists discuss how recent data on androgen receptor pathway inhibitor–based combination regimens highlight their potential to enhance treatment outcomes for advanced prostate cancer, underscoring the importance of integrating these findings into clinical practice.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Treatment Landscape and Sequencing of Therapies
    EP. 2: Treatment Timelines Related to Disease State and Use of Monotherapy
    EP. 3: Genetic Testing – Germline
    Now Viewing
    EP. 4: Recent Data on ARPI-Based Combination Regimens
    EP. 5: Genetic Testing – Somatic
    EP. 6: ARPI-Based Combination Regimens – PEACE-3 (Radium-223 and enzalutamide)
    EP. 7: Use of Bone Protection Agents
    EP. 8: ARPI-Based Combination Regimens – ARANOTE (Darolutamide and ADT)
    EP. 9: ARPI-Based Combination Regimens – CONTACT-02 (Cabozantinib plus atezolizumab)
    EP. 10: ARPI-Based Combination Regimens – SPLASH (177 Lu-PNT-2002)
    EP. 11: Key Takeaways and Looking Ahead

    If you have a patient who comes to your clinic and they are coming in for a second opinion to ensure optimized therapy, do you ever offer 6 cycles of docetaxel?

    Related Content:

    Clinical Updates in Treating Advanced Prostate Cancer
    ARPI-Based Combination Regimens – CONTACT-02 (Cabozantinib plus atezolizumab)
    ARPI-Based Combination Regimens – SPLASH (177 Lu-PNT-2002)
    Key Takeaways and Looking Ahead
    x